Literature DB >> 22235857

DCE-MRI: a review and applications in veterinary oncology.

M Keara Boss1, N Muradyan, D E Thrall.   

Abstract

Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) is a functional imaging technique that assesses the physiology of tumour tissue by exploiting abnormal tumour microvasculature. Advances made through DCE-MRI include improvement in the diagnosis of cancer, optimization of treatment choices, assessment of treatment efficacy and non-invasive identification of prognostic information. DCE-MRI enables quantitative assessment of tissue vessel density, integrity, and permeability, and this information can be applied to study of angiogenesis, hypoxia and the evaluation of various biomarkers. Reproducibility of DCE-MRI results is important in determining the significance of observed changes in the parameters. As improvements are made towards the utility of DCE-MRI and interpreting biologic associations, the technique will be applied more frequently in the study of cancer in animals. Given the importance of tumour perfusion with respect to tumour oxygenation and drug delivery, the use of DCE-MRI is a convenient and powerful way to gain basic information about a tumour.
© 2011 John Wiley & Sons Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22235857      PMCID: PMC3593756          DOI: 10.1111/j.1476-5829.2011.00305.x

Source DB:  PubMed          Journal:  Vet Comp Oncol        ISSN: 1476-5810            Impact factor:   2.613


  50 in total

1.  Improved correlation to quantitative DCE-MRI pharmacokinetic parameters using a modified initial area under the uptake curve (mIAUC) approach.

Authors:  Hai-Ling Margaret Cheng
Journal:  J Magn Reson Imaging       Date:  2009-10       Impact factor: 4.813

2.  Prediction of response to chemoradiation therapy in squamous cell carcinomas of the head and neck using dynamic contrast-enhanced MR imaging.

Authors:  S Kim; L A Loevner; H Quon; A Kilger; E Sherman; G Weinstein; A Chalian; H Poptani
Journal:  AJNR Am J Neuroradiol       Date:  2009-10-01       Impact factor: 3.825

3.  Why do purely intraductal cancers enhance on breast MR images?

Authors:  Christiane K Kuhl
Journal:  Radiology       Date:  2009-11       Impact factor: 11.105

4.  Vascular endothelial growth factor concentrations from platelets correlate with tumor angiogenesis and grading in a spontaneous canine non-Hodgkin lymphoma model.

Authors:  Nicola Zizzo; Rosa Patruno; Francesco Alfredo Zito; Aldo Di Summa; Antonella Tinelli; Sante Troilo; Andrea Misino; Eustachio Ruggieri; Veronica Goffredo; Cosmo Damiano Gadaleta; Girolamo Ranieri
Journal:  Leuk Lymphoma       Date:  2010-02

5.  Hypoxia and radiation therapy: past history, ongoing research, and future promise.

Authors:  Sara Rockwell; Iwona T Dobrucki; Eugene Y Kim; S Tucker Marrison; Van Thuc Vu
Journal:  Curr Mol Med       Date:  2009-05       Impact factor: 2.222

6.  Ultra-early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer.

Authors:  Nina A Mayr; William T C Yuh; David Jajoura; Jian Z Wang; Simon S Lo; Joseph F Montebello; Kyle Porter; Dongqing Zhang; D Scott McMeekin; John M Buatti
Journal:  Cancer       Date:  2010-02-15       Impact factor: 6.860

7.  Reproducibility of perfusion parameters in dynamic contrast-enhanced MRI of lung and liver tumors: effect on estimates of patient sample size in clinical trials and on individual patient responses.

Authors:  Chaan S Ng; David L Raunig; Edward F Jackson; Edward A Ashton; Frederick Kelcz; Kevin B Kim; Razelle Kurzrock; Teresa M McShane
Journal:  AJR Am J Roentgenol       Date:  2010-02       Impact factor: 3.959

Review 8.  Role of hypoxia in the hallmarks of human cancer.

Authors:  Kai Ruan; Gang Song; Gaoliang Ouyang
Journal:  J Cell Biochem       Date:  2009-08-15       Impact factor: 4.429

9.  DCEMRI of spontaneous canine tumors during fractionated radiotherapy: a pharmacokinetic analysis.

Authors:  Ste Søvik; Hege Kippenes Skogmo; Erlend K F Andersen; Øyvind S Bruland; Dag Rune Olsen; Eirik Malinen
Journal:  Radiother Oncol       Date:  2009-09-09       Impact factor: 6.280

10.  Preclinical investigation of PEGylated tumor necrosis factor alpha in dogs with spontaneous tumors: phase I evaluation.

Authors:  Douglas H Thamm; Ilene D Kurzman; Mike A Clark; E J Ehrhart; Susan L Kraft; Daniel L Gustafson; David M Vail
Journal:  Clin Cancer Res       Date:  2010-02-16       Impact factor: 12.531

View more
  6 in total

1.  Dynamic contrast enhanced MR imaging for evaluation of angiogenesis of hepatocellular nodules in liver cirrhosis in N-nitrosodiethylamine induced rat model.

Authors:  Wei Zhang; Hui Juan Chen; Zhen J Wang; Wei Huang; Long Jiang Zhang
Journal:  Eur Radiol       Date:  2016-08-03       Impact factor: 5.315

2.  Dynamic Contrast-Enhanced Magnetic Resonance Imaging with Gd-EOB-DTPA for the Evaluation of Liver Fibrosis Induced by Carbon Tetrachloride in Rats.

Authors:  Wei Zhang; Xiang Kong; Zhen J Wang; Song Luo; Wei Huang; Long Jiang Zhang
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

3.  MRI perfusion analysis using freeware, standard imaging software.

Authors:  Antje Hartmann; Volkher B Scholz; Ines E Lautenschläger
Journal:  BMC Vet Res       Date:  2020-05-18       Impact factor: 2.741

Review 4.  Imaging in Non-neurologic Oncologic Treatment Planning of the Head and Neck.

Authors:  Katherine S Hansen; Michael S Kent
Journal:  Front Vet Sci       Date:  2019-03-28

5.  Comparison of MR-PWI quantitative and semi-quantitative parameters for the evaluation of liver fibrosis.

Authors:  Ke Ding; Manrong Liu; Xue Wei; Ruisui Huang; Jiong Chen; Shanjin Lu; Dacheng Wang; Wei Lu
Journal:  BMC Med Imaging       Date:  2021-01-06       Impact factor: 1.930

6.  Quantitative dynamic contrast-enhanced magnetic resonance imaging in a VX2 rabbit liver tumour model using different gadolinium-based contrast agents: comparison of DCE-MRI quantitative results between Magnevist and Eovist.

Authors:  Yule Zhang; Hongsheng Liu; Weiqiang Xiao; Liling Zhu; Na Wang; Xuehua He; Zhimin Jiang; Buyun Guan
Journal:  BJR Case Rep       Date:  2017-04-12
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.